AOD-9604
Tested in peopleIt has been tested in people, but it is not an approved medicine. The studies are usually small.
Also called hGH Fragment 176-191 / AOD9604 / Tyr-hGH 177-191
A small piece of growth hormone tested for weight loss in people. It did not beat placebo in the main trials.
Can a doctor prescribe this?
No. Pharmacies are not on record as being allowed to make this into a medicine.
The FDA has not approved this as a medicine.
Left the FDA's restricted category in September 2024 when its nomination was withdrawn. It is not on the approved compounding list.
Official status: Not on the 503A bulks list. Checked 2024-09-27.
Lab suppliers we list: 13
Doses used in research
Taken word for word from the studies and trials listed on this page. This is not a recommendation and not a dose for anyone to take.
No dosing information has been published in the research indexed here.
- Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry.
Journal of separation science · 2016
- Detecting peptidic drugs, drug candidates and analogs in sports doping: current status and future directions.
Expert review of proteomics · 2014
- AOD-9604 does not influence the WADA hGH isoform immunoassay.
Drug testing and analysis · 2013
- Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology · 2005
- AOD-9604 Metabolic.
Current opinion in investigational drugs (London, England : 2000) · 2004
- Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology · 2003
- Gateways to clinical trials.
Methods and findings in experimental and clinical pharmacology · 2003
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance
Review of earlier work
Journal not recorded · 2026
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.
Review of earlier work
Sports medicine (Auckland, N.Z.) · 2026
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.
Review of earlier work
Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2026
- Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance
Review of earlier work
Journal not recorded · 2025
- Human Growth Hormone Fragment 176-191 Peptide Enhances the Toxicity of Doxorubicin-Loaded Chitosan Nanoparticles Against MCF-7 Breast Cancer Cells.
Review of earlier work
Drug design, development and therapy · 2022
- Analytical approaches for the detection of emerging therapeutics and non-approved drugs in human doping controls.
Review of earlier work
Journal of pharmaceutical and biomedical analysis · 2014
- Obesity drugs in clinical development.
Review of earlier work
Current opinion in investigational drugs (London, England : 2000) · 2006